Shenzhen Yunma Biotechnology Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Shenzhen Yunma Biotechnology General Information

Description

Provider of water-soluble cannabidiol (CBD) formulation technologies for consumer and pharmaceutical applications in Asia (excluding Japan).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • China
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenzhen Yunma Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shenzhen Yunma Biotechnology‘s full profile, request access.

Request a free trial

Shenzhen Yunma Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shenzhen Yunma Biotechnology‘s full profile, request access.

Request a free trial

Shenzhen Yunma Biotechnology FAQs

  • When was Shenzhen Yunma Biotechnology founded?

    Shenzhen Yunma Biotechnology was founded in 2019.

  • Where is Shenzhen Yunma Biotechnology headquartered?

    Shenzhen Yunma Biotechnology is headquartered in China.

  • What industry is Shenzhen Yunma Biotechnology in?

    Shenzhen Yunma Biotechnology’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Shenzhen Yunma Biotechnology a private or public company?

    Shenzhen Yunma Biotechnology is a Private company.

  • What is Shenzhen Yunma Biotechnology’s current revenue?

    The current revenue for Shenzhen Yunma Biotechnology is .

  • Who are Shenzhen Yunma Biotechnology’s investors?

    Lifetech Scientific and Sorrento Therapeutics have invested in Shenzhen Yunma Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process